entertainment -WSS

entertainment

author：explore 2025-09-28 13:25:55 - browse：4544

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Biden warns of ‘dark winter’ during final presidental debate

Wikipedia

WSS

First Opinion Podcast: Long Covid needs a new approach

New Alzheimer's drugs heat up race for early detection blood tests

Studies point to risks of excluding people with obesity from drug trials

The explosion of genetic testing requires a new approach

UnitedHealth’s board chair also owns a personal investment firm

FDA struggles to regulate food additives, sometimes for decades

Wikipedia

entertainment

focus

New air purifier tech could be key to improving indoor air quality

UnitedHealth’s board chair also owns a personal investment firm

As demand for Covid shots wanes, Moderna seeks its next success

Democrats decry new health bill for going easy on private equity

23andMe had bad news about my health. I wish a person had delivered it

Will the FTC rein in IQVIA's health data empire?

Medical leaders decry Supreme Court decision on affirmative action

Will the FTC rein in IQVIA's health data empire?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly expects to double planned employment in Boston center

leisure time

STAT Summit: Biotech founders on deal

Studies point to risks of excluding people with obesity from drug trials

FDA warns J&J's Abiomed: We will regulate your software

Medicare reduced heart disease by changing how it pays doctors

NIH confirmation hearing shows politicization of research

2023 STAT Wunderkinds: get to know the winners

Wikipedia

focus

explore

focus